# US 2011/0300225 A1 · Nutritional compositions with coated lipid globules

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0300225 A1
- Document ID: US20110300225A1
- Status: Published application
- Kind: A1
- Application number: 13/133,924
- Filed: 2009-12-11
- Published: 2011-12-08
- Earliest claimed: 2008-12-11
- Assignees: N.V. Nutricia
- Inventors: Eline Marleen Van Der Beek; Gelske Speelmans; Annemarie Oosting; Antonie Van Baalen; Marieke Abrahamse-Berkenveld; Günther Boehm
- Web page: https://patentgrep.com/patent/US20110300225A1

## CPC

- A61K 36/02: Algae
- A23L 33/115: Fatty acids or derivatives thereof; Fats or oils
- A23L 33/12: Fatty acids or derivatives thereof
- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A61K 9/1276: Globules of milk; Constituents thereof
- A61K 9/14: Particulate form, e.g. powders, {Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles (microspheres A61K9/16; microcapsules A61K9/50; nanocapsules, nanoparticles of the matrix type A61K9/51)}
- A61K 31/20: having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K 31/202: having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557)
- A61K 31/575: substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A61K 31/688: both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
- A61K 35/20: Milk; Whey; Colostrum
- A61K 35/60: Fish, e.g. seahorses; Fish eggs
- A61K 35/66: Microorganisms or materials therefrom (fungi, yeasts or candida A61K36/06)
- A61K 36/06: Fungi, e.g. yeasts
- A61P 3/06: Antihyperlipidemics
- A61P 19/00: Drugs for skeletal disorders
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61P 19/10: for osteoporosis
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a lipid globules coated with phospholipids. The composition is used for increasing bone mineral content, bone mineral density, preventing osteoporosis, and/or preventing ostopenia.

## Claims

### Claim at position 1

1-15. (canceled)

### Claim 16

A method of increasing bone mass density and/or increasing bone mineral content, comprising administering to a human subject in need thereof a composition comprising:
(a) 10 to 50 wt. % of vegetable lipids, based on dry weight of the composition, and
(b) 1.0 to 20 wt. % of phospholipids, based on total lipid,
wherein the vegetable lipids and the phospholipids are in lipid globules with a core comprising said vegetable lipids and a coating comprising said phospholipids lipids.

### Claim 17 (depends on 16)

The method according to claim 16, wherein the human subject is between 0 and 36 months of age.

### Claim 18 (depends on 16)

The method according to claim 16, wherein the human subject is 36 months of age or older.

### Claim 19 (depends on 18)

The method according to claim 18, wherein the human subject is above 5 years of age.

### Claim 20 (depends on 16)

The method according to claim 16, wherein the lipid globules comprise:
i) a volume-weighted mode diameter below 1.0 μm, and
ii) a diameter of 2 to 12 μm in an amount of at less than 45 volume % based on total lipid.

### Claim 21 (depends on 20)

The method according to claim 20, wherein the lipid globules comprise:
(i) a volume-weighted mode diameter in the range of 0.3-0.6 μm, and
(ii) a size distribution wherein more than 55 volume % of the lipid globules has a diameter of less than 2 μm.

### Claim 22 (depends on 16)

The method according to claim 16, wherein the lipid globules comprise:
(i) a volume-weighted mode diameter above 1.0 μm, and
(ii) a diameter of 2 to 12 μm in an amount of at least 45 volume % based on total lipid.

### Claim 23 (depends on 22)

The method according to claim 22, wherein the lipid globules comprise:
(i) a volume-weighted mode diameter in the range of 1.0-10 μm, and
(ii) diameter of 2 to 12 μm in an amount of at least 55 volume % based on total lipid.

### Claim 24 (depends on 16)

The method according to claim 16, wherein the phospholipids are derived from milk lipids.

### Claim 25 (depends on 16)

The method according to claim 16, wherein the composition further comprises glycosphingolipids, cholesterol, or both.

### Claim 26 (depends on 25)

The method according to claim 25, wherein the composition comprises 1.0 to 25 wt. % of polar lipids based on total lipids, wherein polar lipids are the sum of phospholipids, glycosphingolipids and cholesterol.

### Claim 27 (depends on 16)

The method according to claim 16, wherein the composition has a fatty acid profile with a linoleic acid to alpha-linolenic acid weight ratio between 4 and 7.

### Claim 28 (depends on 16)

The method according to claim 16, wherein the lipids comprise at least 16 wt. % palmitic acid based on total fatty acids of the composition.

### Claim 29 (depends on 26)

The method according to claim 26, wherein over 75 wt. % of the palmitic acid is in the sn-1 or sn-3 position.

### Claim 30 (depends on 16)

The method according to claim 16, wherein the composition further comprises least one lipid selected from the group consisting of fish oil, marine oil, algal oil, fungal oil and microbial oil.

### Claim 31 (depends on 16)

The method according to claim 16, wherein the composition further comprises non-digestible oligosaccharides.

### Claim 32

A method of treating and/or preventing osteoporosis and/or osteopenia, comprising administering to a human subject in need thereof a composition comprising:
(a) 10 to 50 wt. % of vegetable lipids, based on dry weight of the composition, and
(b) 1.0 to 20 wt. % of phospholipids, based on total lipid,
wherein the vegetable lipids and the phospholipids are in lipid globules with a core comprising said vegetable lipids and a coating comprising said phospholipids lipids.3) The use according to any of the preceding claims, wherein the nutritional composition is further for prevention of obesity.

### Claim 33 (depends on 32)

The method according to claim 32, wherein the lipid globules comprise:
i) a volume-weighted mode diameter below 1.0 μm, and
ii) a diameter of 2 to 12 μm in an amount of at less than 45 volume % based on total lipid.

### Claim 34 (depends on 32)

The method according to claim 32, wherein the lipid globules comprise:
(i) a volume-weighted mode diameter above 1.0 μm, and
(ii) a diameter of 2 to 12 μm in an amount of at least 45 volume % based on total lipid.

### Claim 35 (depends on 32)

The method according to claim 32, further comprising at least 16 wt. % palmitic acid based on total fatty acids of the composition.
